US Edition
News from Pharmacy Times
We’ve assigned a rating of Unknown factuality to Pharmacy Times. You can read more about how we’ve determined Pharmacy Times’s credibility and reliability as a news source here: https://groundnews.lakegeneva.lib.wi.us/rating-system.
Media Bias Ratings
Do you diasgree?
Edit bias
Learn more about Media Bias Ratings.
Factuality
Learn more about Factuality Ratings
Reveal Factuality Ratings by upgrading to a Premium account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Ownership
Learn more about Ownership categories
Reveal Ownership Data by upgrading to a Vantage account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Top Pharmacy Times News
Hepatitis C · United StatesEditor's Note: This headline and story have been updated to clarify that the FDA approval was for an expanded indication to treat acute HCV. The U.S. Food and Drug Administration (FDA) approved a label expansion for AbbVie Inc's (NYSE:ABBV) Mavyret (glecaprevir/pibrentasvir) to include treatment of acute hepatitis C virus (HCV) infection in patients without cirrhosis or with compensated cirrhosis. Glecaprevir, one of the two DAAs in Mavyret, was…See the Story
FDA Expands AbbVie's Mavyret Label To Include Acute Hepatitis C Treatment (CORRECTED) - Enanta Pharma (NASDAQ:ENTA), AbbVie (NYSE:ABBV)
73% Center coverage: 15 sources
NHSA Cleveland Clinic study shows that semaglutide and tirzepatide – injectable GLP-1 drugs for obesity – produce smaller weight loss in a real-world setting because patients discontinue treatment or use lower maintenance dosages.See the Story
Real-World Study Finds Lower Weight Loss with GLP-1 Drugs Due to Early Discontinuation
34% Center coverage: 9 sources
Breast CancerFor Thursday, June 12, WGN’s Dina Bair has the latest on new medical information, including:
More Coverage: WGN's Medical Watch Benefits of Vitamin D fighting breast cancer — and more An added bonus from taking Vitamin D? It could help fight cancer Vitamin D increases the likelihood that breast cancer treatment will work. Researchers at São Paulo State University studied breast cancer patients older than 45. They discovered, those who too…See the Story
Benefits of Vitamin D Fighting Breast Cancer
100% Center coverage: 4 sources
Merck's Keytruda Secures FDA Nod For Head And Neck Cancer As First Immunotherapy For Use Around Surgery - Merck & Co (NYSE:MRK)
100% Center coverage: 3 sources
Next-Generation TKI Approved for Advanced ROS1-Positive Lung Cancer
100% Center coverage: 2 sources
